1Department of Chemistry and Biochemistry, and UCLA-DOE Laboratory of Structural Biology and Molecular Medicine, Los Angeles, CA, 90095, USA.
High-affinity small molecule drugs require rough protein surfaces for effective binding. Future drug design should focus on targeting these rough protein areas for improved pharmaceutical development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: